Greenberg Richard S 4
4 · NEXIEN BIOPHARMA, INC. · Filed Oct 18, 2022
Insider Transaction Report
Form 4
Greenberg Richard S
DirectorEVP and Chairman10% Owner
Transactions
- Award
Common Stock
2022-10-17+250,000→ 5,185,193 total
Holdings
- 1,062,953
Class C Warrant
Exercise: $0.05From: 2020-11-24Exp: 2025-11-24→ common stock (1,062,953 underlying) - 150,000
Options to purchase common stock (right to buy)
Exercise: $0.54From: 2018-07-25Exp: 2025-07-25→ common stock (150,000 underlying) - 1,062,953
Class A Warrant
Exercise: $0.04From: 2020-11-24Exp: 2025-11-24→ common stock (1,062,953 underlying) - 2,500,000
Options to purchase common stock (right to buy)
Exercise: $0.08From: 2020-08-19Exp: 2027-08-19→ common stock (2,500,000 underlying) - 100,000
Options to purchase common stock (right to buy)
Exercise: $0.66From: 2018-10-26Exp: 2025-10-26→ common stock (100,000 underlying) - 1,062,953
Class B Warrant
Exercise: $0.04From: 2020-11-24Exp: 2025-11-24→ common stock (1,062,953 underlying) - 40,000
Convertible note
Exercise: $0.04From: 2020-11-24Exp: 2023-11-24→ common stock (1,062,953 underlying)
Footnotes (1)
- [F1]Issued in lieu of compensation for services.